| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.32B | 89.45B | 77.33B | 71.58B | 69.20B | 75.76B |
| Gross Profit | 22.13B | 21.72B | 17.85B | 16.82B | 16.32B | 16.83B |
| EBITDA | 4.07B | 3.85B | 3.54B | 2.92B | 2.93B | 3.36B |
| Net Income | 1.60B | 1.50B | 1.45B | 1.19B | 1.33B | 1.40B |
Balance Sheet | ||||||
| Total Assets | 39.84B | 40.52B | 38.54B | 33.86B | 32.52B | 32.95B |
| Cash, Cash Equivalents and Short-Term Investments | 3.13B | 4.46B | 3.96B | 2.36B | 1.24B | 2.87B |
| Total Debt | 5.26B | 6.27B | 6.79B | 5.33B | 5.32B | 6.22B |
| Total Liabilities | 18.64B | 19.73B | 19.17B | 16.08B | 15.81B | 17.48B |
| Stockholders Equity | 21.20B | 20.80B | 19.37B | 17.78B | 16.72B | 15.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.76B | 2.73B | 1.68B | 99.34M | 2.19B |
| Operating Cash Flow | 0.00 | 3.10B | 3.78B | 2.54B | 1.73B | 3.37B |
| Investing Cash Flow | 0.00 | -1.37B | -2.89B | -864.63M | -1.95B | -1.18B |
| Financing Cash Flow | 0.00 | -1.23B | 700.91M | -556.83M | -1.41B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.94B | 14.34 | ― | 1.65% | ― | ― | |
74 Outperform | ¥18.66B | 10.84 | ― | 2.12% | 12.92% | -30.67% | |
73 Outperform | ¥12.40B | 7.01 | ― | 2.30% | 10.43% | 12.10% | |
71 Outperform | ¥74.17B | 11.40 | ― | 1.34% | 20.50% | 10.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | ¥12.62B | 29.59 | ― | 2.32% | 2.43% | 50.53% | |
48 Neutral | ¥4.08B | 25.11 | ― | 0.67% | 5.74% | 14.35% |